Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Gilead Sciences (GILD.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-2558.9165.00Neutral
2022-05-1262.4864.00Neutral
2022-07-1962.1263.00Neutral
2022-08-0362.2765.00Neutral
2022-10-2167.7966.00Neutral
2022-10-2879.2771.00Neutral
2023-01-2983.7385.00Neutral
2023-02-0686.3690.00Neutral
2023-04-2084.6991.00Neutral
2023-05-0181.4288.00Neutral
2023-08-0780.6784.00Neutral
2023-11-0180.1985.00Neutral
2023-11-1075.9281.00Neutral
2024-01-2479.5380.00Neutral
2024-02-0774.4281.00Neutral
2024-04-1766.9375.00Neutral
2024-05-0165.5170.00Neutral
2024-11-0590.22-No Rating
2024-11-0691.6970.00Neutral
2024-11-1888.46-No Rating
2024-11-2189.7696.00Neutral
2025-06-04109.02108.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.